Aarti Drugs Shareholding Pattern
- Market cap
- ₹3,804 crore
- P/E
- 19.9
- P/B
- 2.46
- ROE
- 13.4%
- Dividend yield
- 1.20%
As of 30-JUN-2026, promoters held 54.43% of Aarti Drugs (-0.60 pp from 31-MAR-2026), foreign institutional investors 1.52%, domestic institutions 10.29% and the public 33.75%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Aarti Drugs shareholding pattern — frequently asked questions
What is the promoter holding in Aarti Drugs?
Promoters held 54.43% of Aarti Drugs as of 30-JUN-2026, down 0.60 pp from 55.03% in 31-MAR-2026.
How much do FIIs hold in Aarti Drugs?
Foreign institutional investors held 1.52% of Aarti Drugs as of 30-JUN-2026, a change of -0.06 pp from the previous quarter.
How much do domestic institutions hold in Aarti Drugs?
Domestic institutional investors, including mutual funds and insurers, held 10.29% of Aarti Drugs as of 30-JUN-2026 (+0.07 pp from the previous quarter).
Who owns Aarti Drugs?
As of 30-JUN-2026, Aarti Drugs' shareholders were promoters (54.43%), foreign institutional investors 1.52%, domestic institutions 10.29% and the public 33.75%, as filed with the stock exchanges.
Same Data For Peers
Trade Aarti Drugs With ATS
Track AARTIDRUGS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.